Replies to post #34013 on Amarantus Bioscience Holdings Inc (AMBS)

[Drano]

With the euphoria from the congressional vote, I'm not so sure we're going to get a chance for cheap shares. :-(

[michelebucks]

AMBS will never see single pennies again. If you wait for a dip u are one. Do not listen to any individual that wants AMBS to correct. It is not going to happen. The day of the MM games are over. Those who play AMBS to save a penny are foolish. The shorts will get crushed Tuesday to Friday. AMBS will be $2 dollars plus by Valentines day. Big money from outside the Investors Hub world is investing in AMBS. Get in or miss out. Blue sky all January.

[cjstocksup]

Here is my take on AMBS facts only. Last Thursday we saw some of our debtors come in in the last hour and take AMBS down almost 50% off the highs in less than an hour. We have alot of debtors as listed below. They were wise to start then IMO so they would not get stuck not being able to sell in the cusip change holding period. Thie debt I will show below is only through Sept. There was more debt issued into Nov. These are the MM's that began the sell off last Thursday. These are not retail these are all big $$$. MICA, PERT, BMAK, MERQ and WORL, VNDM, VFIN etc. No one knows who will get their shares available to sell first and when but when it does happen IMO you will see a major sell off. Most who have been wanting to sell and tke profits since last Friday have been unable and will be wanting to get out with profits before everyone else IMO. These are all debtholders who have AMBS shares to convert or sell into the open market. And these are only up until Sept. There was more debt added since. " As of September 30, 2012 the Company had outstanding $1,311,800 of convertible note principal. These convertible notes, along with related accrued interest, convert upon the Next Equity Financing or at the option of the note holder. These notes convert at various rates ranging from established conversion prices to variable discounted prices calculated as an average or the lowest trading prices over a certain number or prior trading days. Some notes have warrants that range from



$17,000 of convertible debt principal have interest at 5% and warrants equivalent to 20% of the principal balance, respectively, and convert upon the next equity financing.



$500,000 of convertible note principal and related accrued interest convert at two-thirds the price per share of the Next Equity Financing and have warrants equivalent to 100% of the principal balance



$230,000 of convertible note principle and related accrued interest convert at $0.04 per share.



$283,688 of convertible note principal having interest at 6%, can convert at prices ranging from $0.002 to $0.165 per share at anytime at the option of the note holder, and have no warrants. As of September 30, 2012, $83,750 of the principal of this $283,688 convertible debt has converted to common shares.



$90,000 of convertible note principal having interest at 6%, can convert at $0.10 or $0.20 per share at anytime at the option of the note holder and warrants equivalent to 100%. As of September 30, 2012, $57,000 of the principal of this $90,000 convertible debt has converted to common shares.
F- 18
Table of Contents

$244,988 of convertible note principal, having an interest rate of 8.5%. no warrants, can convert at $0.11 per share at anytime at the option of the note holder.



$91,500 of convertible note principal, having and interest rate of 8%, no warrants, can convert at 50-55% of the average of the two-three lowest trading days of the prior 10-60 trading days, there is a 180 day waiting period before the holder has the option to convert to common shares. As of September 30, 2012, $26,767 has converted to common stock.



$9,500 of convertible note principle was issued as part of a unit debt instrument which consisted of a return on investment (“ROI”) agreement and a convertible promissory note in return for $10,000. The ROI has a redemption value of $10,500 due on demand and the convertible promissory note is for $9,500, non-interest bearing, due September 20, 2012, and is convertible to common shares after six months from the date of the note at a conversion price that is 50% of the lowest trading price over the 20 prior trading dates from the date of conversion notice. The common share effect of the convertible debt is not included in the above schedule since the number of shares will not be determinable until the Next Equity Financing. (See Note 8). This convertible note converted to common shares in September 2012.



$30,000 of convertible note principal, having interest of 12% per annum, compounded monthly, can convert any time at the option of the note holder, conversion at 55% of the lowest trading price over the prior three trading days from the date of conversion. As of September, 2012 this note has been assigned.



$21,500 of convertible note principal, having interest of 12% per annum, can convert anytime at the option of the note holder, can convert at 55% of the average of the three lowest trading prices over the prior ten trading days from the date of conversion.



$30,880 of convertible note principal, having interest of 12% per annum, compounded monthly, can convert any time at the option of the note holder, conversion at 55% of the lowest trading price over the prior three trading days from the date of conversion. As of September, 2012 this note has been assigned. Also in September, 2012, the note holder converted $10,805 of the principal into common shares of the Company.



$72,000 of convertible notes principal, having interest of 12% per annum, compounded monthly, can convert any time at the option of the note holder, conversion at 50% of the lowest trading price over the prior twenty trading days from the date of conversion. As of September, 2012 this note has been assigned. Also in September, 2012, the note holder converted all of the $30,000 note principal into common shares of the Company.



The common share effect of the warrants related to the following convertible debt has been included in the above schedule.



During the nine months ended September 30, 2012 the Company issued $1,746,497 worth of common stock, $1,272,412 to various consultants for services, it paid $54,442 of trade accounts payable with shares of common stock in settlement of the trade debt and it paid $419,643 to acquire rights to certain technology.
F- 19
Table of Contents "

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8926855